MedTrace Logo

Phase II Evaluation of Exhaled Nitric Oxide (NO)

NCT01392144 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2013-04-04

No results posted yet for this study

Summary

The goal of this clinical research study is to learn if the level of nitric oxide you breathe out may relate to the amount of breathing complications that you may experience due to radiation treatment.

Conditions

Interventions

PROCEDURE

Nitric oxide breath test

Breathe out into a device (nitric oxide breath analyzer) for 10 seconds; repeated 3 times. Done prior to start of radiation therapy, 1 week before completion of radiation therapy, at completion of radiation therapy, then at each follow-up visit for 6 months.

BEHAVIORAL

Questionnaires

On day of each breathing test, completion of a breathing and symptom questionnaire, approximately 10 minutes.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Thomas Guerrero, MD, PHD · UT MD Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01392144 on ClinicalTrials.gov